PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-29.30%
Negative net income growth while MCHP stands at 18.24%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-2.94%
Negative yoy D&A while MCHP is 14.27%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
121.68%
Well above MCHP's 187.58% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
21.28%
SBC growth well above MCHP's 0.08%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-268.71%
Negative yoy working capital usage while MCHP is 33.30%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-118.57%
AR is negative yoy while MCHP is 61.21%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-73.63%
Both reduce yoy inventory, with MCHP at -66.23%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-239.39%
Both reduce yoy usage, with MCHP at -46.11%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
100.00%
Well above MCHP's 3.24%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-58.05%
Negative yoy CFO while MCHP is 23.41%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
35.55%
Some CapEx rise while MCHP is negative at -77.73%. John Neff would see competitor possibly building capacity while we hold back expansions.
100.00%
Acquisition growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-24.54%
Negative yoy purchasing while MCHP stands at 26.69%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
153.36%
We have some liquidation growth while MCHP is negative at -22.22%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-100.00%
We reduce yoy other investing while MCHP is 18.32%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
111.50%
We have mild expansions while MCHP is negative at -167.57%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
21.95%
We slightly raise equity while MCHP is negative at -59.16%. John Neff sees competitor possibly preserving share count or buying back shares.
-28.50%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.